U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2017, Business and Industry Statistics


U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2017


 

January

February

March

April

May

June


Standard

10

4

6

5

4

5


Priority

0

0

4

2

2

3


Standard (Orphan)

2

0

0

3

3

2




A Representative List of Organizations that Have Used our Research and Products: